Successful trial for plaque psoriasis treatment

Israel’s Scinai Immunotherapeutics has announced successful preclinical trial results of its innovative anti‑IL‑17 VHH antibody (‘NanoAb’) as a local treatment for the large and underserved population of patients with mild to moderate plaque psoriasis.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *